인성크로마텍 로고

검색버튼
퀵메뉴 펼침

o
p
e
n
c
l
o
s
e

Libraries

라이브러리


연구자료

기초 분석 원리 및 최신 연구 자료가 소개되어 있습니다.
  • 홈으로home
  • > 라이브러리 >
  • 연구자료
[PLGA ] Using SEC-MALS-IV to Characterize PLGA for FDA Generic Drug Approval
인성크로마텍(주)
Date : 2020.03.27

 

Using SEC-MALS-IV to Characterize PLGA for 

FDA Generic Drug Approval 

  


•  Presented By : Chris Deng, Ph.D., Wyatt Technology 

•  Presented Live : November 14, 2019 

 

Traditionally, size exclusion chromatography (SEC) with column calibration is used to obtain the molar mass distributions of 

polymers such as PLGA. However, this technique has significant drawbacks as it assumes the standards used for calibration

are physically similar to the sample, of particular concern for copolymers and other non-standard macromolecules. 

In comparison, multi-angle light scattering utilizes first principles to obtain a truly accurate molar mass measurement. 

Combined with a differential viscometer to measure intrinsic viscosity (IV), SEC-MALS produces a bevy of useful information

from PLGA analysis, including branching ratio and conformation. 

 


Wyatt 웨비나.PNG


Using SEC-MALS-IV to Characterize PLGA for FDA Generic Drug Approval from Wyatt Technology on Vimeo.